Document Detail

Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions.
MedLine Citation:
PMID:  17215197     Owner:  NLM     Status:  MEDLINE    
The aims of this study were to obtain the most recent representative data for the prevalence of diabetes in adult populations in the World Health Organisation's South-East Asia and Western Pacific regions and to quantify the contribution of diabetes to the burden of mortality from cardiovascular diseases in these regions. Previous reports indicate that there are 83 million individuals with diabetes in the Asia-Pacific region, but since many of the country-specific estimates were not from nationally representative studies, this figure may not accurately reflect the current burden of diabetes. Information on the prevalence of diabetes was obtained by searching Medline and government health websites. Data were available from 12 countries representing 78% of the total population of the Asia-Pacific region. Six of 10 countries with complete data reported a prevalence of diabetes exceeding those estimates currently cited by the World Health Organization; three of which have also already exceeded the World Health Organization projections for 2030. In the 12 countries in the region with nationally representative data, the prevalence of diabetes ranged from 2.6% to 15.1%. Hazard ratios from the Asia Pacific Cohort Studies Collaboration were used to calculate population attributable fractions for diabetes for fatal cardiovascular diseases in the region. Population attributable fractions ranged from 2% to 12% for coronary heart disease, 1% to 6% for haemorrhagic stroke, and 2% to 11% for ischaemic stroke. Accurate estimates of the prevalence of diabetes are of great importance and standard methods are needed for periodic surveillance across the Asia-Pacific region and elsewhere.
Crystal Man Ying Lee; Rachel R Huxley; Tai Hing Lam; Alexandra Lynda Conboy Martiniuk; Hirotsugu Ueshema; Wen-Harn Pan; Tim Welborn; Mark Woodward;
Related Documents :
24712877 - Effects of the antitumor drug osi-906, a dual inhibitor of igf-1 receptor and insulin r...
24891017 - Cathepsin s inhibition lowers blood glucose levels in mice.
9002387 - An epidemiological study on diabetes mellitus in the population living in a methyl merc...
8422787 - Diabetes prevalence, incidence, and complications among alaska natives, 1987.
11438497 - Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver ...
16253367 - The comparative ability of four isolates of bacillus subtilis to ferment soybeans into ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Asia Pacific journal of clinical nutrition     Volume:  16     ISSN:  0964-7058     ISO Abbreviation:  Asia Pac J Clin Nutr     Publication Date:  2007  
Date Detail:
Created Date:  2007-01-11     Completed Date:  2007-04-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9440304     Medline TA:  Asia Pac J Clin Nutr     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  187-92     Citation Subset:  IM    
The George Institute for International Health, PO Box M 201, Missenden Road, Sydney, NSW 2050, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Asia, Southeastern / epidemiology
Coronary Disease / etiology,  mortality*
Cost of Illness*
Diabetes Mellitus, Type 2 / complications,  epidemiology*
Middle Aged
Pacific Islands / epidemiology
Stroke / etiology,  mortality*
World Health Organization

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anthropometric and biochemical markers for nutritional risk among residents within an Australian res...
Next Document:  Time-lag estimate between dietary intake and breast cancer mortality in Japan.